Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-01
2011-03-01
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07897773
ABSTRACT:
The present invention is related to a compound of formula (I)wherein R1a, R1b, R1c, R1d, R2a, R2b, R3, R4, p, r andare as defined herein, its preparation, pharmaceutical composition and use as a modulator of the activity of the 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1).
REFERENCES:
patent: 0130795 (1985-01-01), None
patent: 1283199 (2003-02-01), None
patent: WO 92/22552 (1992-12-01), None
patent: WO 03/031436 (2003-04-01), None
patent: 03/106456 (2003-12-01), None
patent: WO 2004/033427 (2004-04-01), None
patent: 2004/089896 (2004-10-01), None
patent: WO 2005/047250 (2005-05-01), None
patent: WO 2006/053024 (2006-05-01), None
patent: WO 2006/055752 (2006-05-01), None
patent: WO 2006/105127 (2006-10-01), None
patent: WO 2006/132436 (2006-12-01), None
West, Anthony Solid State Chemistry and its applications, John Wiley & Sons 1984, p. 358.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface p. 1-15.
Andrews, R. C., et. al., Effects of the 11B-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol. 88, No. 1, pp. 285-291, (2003).
Barf, T. et. al., Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11 Beta-Hydroxysteroid Dehydrogenase Type 1, American Chemical Society, (2002), vol. 45, No. 18, pp. 3813-3815.
Buffat, M. G. P., et. al., Synthesis of Piperidines, Tetrahedron, vol. 60, (2004), pp. 1701-1709.
Cooper, M. S., et. al., Expression and Functional Consequences of 11B-Hydroxysteroid Dehydrogenase Activity In Human Bone, Bone, vol. 27, No. 3, (2000), pp. 375-381.
Coudert, G., et. al., A New Synthesis of 3,4-Dibhydro-2H-1, 4-Benzoxazines Using Solid-Liquid Phase-Transfer Catalysis, Synthesis, vol. 7, pp. 541-543, (1979).
Davani, B., et. al., Type 1 11B-Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets , The Journal of Biological Chemistry, vol. 275, No. 45, pp. 34841-34844, (2000).
Grzyb, J. A., et. al., Carbamoylimidazolium and Thiocarbamoylimidazolium Salts: Novel Reagents for the Synthesis of Ureas, Thioureas, Carbamates, Thiocarbamates and Amides, Tetrehedron 61, 30 (2005) pp. 7153-7175.
Hermanowski-Vosatka, A., et. al., 11B-HSD1 Inhibition Ameliorates Metabolic Syndrome and Prevents Progresion of Atherosclerosis in Mice, J. Exp. Med., vol. 202, pp. 517-527, (2005).
Kotelevtsev, Y., et. al., 11B-Hydroxysteroid Dehydrogenase Type 1 Knockout Mice Show Attenuated Glucocorticoid-Inducible Responses and Resist Hyperglycemia on Obesity or Stress, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 14924-14929, (1997).
Kuwabe, S., et. al., Palladium-Catalyzed Intramolecular C-O Bond Formation, J. Am. Chem. Soc. (2001), vol. 123, pp. 12202-12206.
Laschat, S., et. al., Stereoselective Synthesis of Piperidines, Synthesis (2000), vol. 13, pp. 1781-1813.
Lupien, S. J., et. al., Cortisol Levels During Human Aging Predict Hippocampal Atrophy and Memory Deficits, Nat. Neurosci., vol. 1, pp. 69-73, (1998).
Masuzaki, H., et. al., A Transgenic Model of Visceral Obesity and The Metabolic Syndrome, Science, vol. 294, pp. 2166, (2001).
Masuzaki, H., et. al., Transgenic Amplification of Glucocorticoid Action in Adipose Tissue Causes High Blood Pressure in Mice, J. Clinical Invest., vol. 112, pp. 83-90, (2003).
Matsuzawa, Y., et. al., Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines Adipocyte-derived Bioactive Substances, Acad. Sci. vol. 892, pp. 146-154, (1999).
McEwen, B. S., et. al., Stress and Cognitive Function, Curr. Opin. Neurobiol., vol. 5, pp. 205-216, (1995).
Moisan, M-P., et. al., 11B-Hydroxysteroid Dehydrogenase Bioactivity and Messenger RNA Expression in Rat Forebrain: Localization in Hypothalamus, Hippocampus, and Cortex. Endocrinology, vol. 127, pp. 1450-1455, (1990).
Morton, N. M., et. al., Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11B-Hydroxysteroid Dehydrogenase Type 1 Null Mice, J. Biol. Chem., vol. 276, pp. 41293-41300.
Rauz, S., et. al., Expression and Putative Role of 11B-Hydroxysteroid Dehydrogenase Isozymes within the Human Eye, Invest. Ophtamol. Vis. Sci., vol. 42, pp. 2037-2042, (2001).
Reaven, G. M., et. al., Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition , Ann. Rev. Med., vol. 44, pp. 121-134, (1993).
Rocha, B. A., et. al., 11beta-Hydroxsteroid Dehydrogenase Type 1 (11 beta-HSD1) Inhibition Prolonged Memory Retention in Mice, Abstract 231 ACS Meeting, Atlanta Mar. 26-30, 2006.
Sandeep, T. C., et. al., 11B-Hydrosteroid Dehydrogenase Inhibition Improves Cognitive Function in Healthy Elderly Men and Type 2 Diabetics, Proc. Natl. Acad. Sci., vol. 101, pp. 6734-6738, (2004).
Shankaran, K., et. al., Syntheses and SAR Studies of 4-(Heteroarylpiperdin-1-yl-Methyl)-Pyrrolidin-1-yl-Acetic Acid Antagonists of the Human CCR5 Chemokine Receptor, Bioorganic & Medicinal Chemistry Letters, vol. 14, (2004), pp. 3419-3424.
Stokes. J., et. al., Distribution of Glucorticoid and Mineralocorticoid Receptors and 11B-Hydroxysteroid Dehydrogenases in Human and Rat Ocular Tissues, Invest. Ophthalmol. Vis. Sci., vol. 41, pp. 1629-1638, (2000).
Terao, Y., et. al., Trifluoroacetic Acid-Catalyzed 1,3-Cycloaddition of the Simplest Iminium Ylide Leading to 3-or 3,4-Substituted Pyrrolidines and 2,5-Dihydropyrroles, Chem. Pharm. Bull. (1985), vol. 33, No. 7, pp. 2762-2766.
Tomlinson, J. W., et. al., 11B-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response, Endocrine Reviews, vol. 25, No. 3, pp. 831-866 (2004).
Wajchenberg, B. L., et. al., Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome, Endocrine Reviews, vol. 21, No. 6, pp. 697-738, (2000).
Wang, S. J. Y., et. al., Inhibition of 11B-Hydroxysteroid Dehydrogenase Type1 Reduces Food Intake and Weight Gain but Maintains Energy Expenditure in Diet-Induced Obese Mice, Diabetologia, (2006), vol. 49, pp. 1333-1337.
Yau, J. L. W., et. al., Lack of Tissue Glucocorticoid Reactivation in 11B-Hydroxysteroid Dehydrogenase Type 1 Knockout Mice Ameliorates Age-Related Learning Impairments, Proc. Natl. Acad. Sci., vol. 98, pp. 4716-4721, (2001).
Lu, Z., et. al., Substituted Bridged Phenyl Piperidines: Orally Active Growth Hormone Secretagogues, Bioorganic & Medicinal Chemistry Letters, vol. 13, (2003), pp. 1817-1820.
Gilbert, A. M., et. al., Modulation of Selective Serotonin Reuptake Inhibitor and 5-HT1A Antagonist Activity in 8-Aza-Bicyclo[3.2.1.]Octane Derivatives of 2,3-Dihydro-1,4-Benzodioxane, Bioorganic & Medicinal Chemistry Letters, vol. 14, (2004), pp. 515-518.
Sikazwe, D. M. N., et. al., Haloperidol: Toward Further Understanding of the Structural Contributions of its Pharmacophoric Elements at D2-Like Receptors, Bioorganic & Medicinal Chemistry Letters, vol. 14, (2004), pp. 5739-5742.
Aletru Michel
Braun Alain Jean
Gussregen Stefan
Mougenot Patrick
Namane Claudie
Chandrakumar Nizal S
Lin Jiang
Sanofi-Aventis
Seaman D. Margaret
LandOfFree
Urea derivatives of tropane, their preparation and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea derivatives of tropane, their preparation and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea derivatives of tropane, their preparation and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2648045